JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
776
StepStone Group
STEP
$3.73B
| $104M | 0.01% |
4,297,392
+215,867
| +5% | +$5.9M |
2020 Q3
10 quarters
|
|
777
Elanco Animal Health
ELAN
$11.1B
| $104M | 0.01% |
11,073,913
+7,516,372
| +211% | +$88.7M |
2018 Q3
18 quarters
|
|
778
Globus Medical
GMED
$10.2B
| $104M | 0.01% |
1,837,425
+498,592
| +37% | +$32M |
2015 Q4
29 quarters
|
|
|
779
CALL
Eli Lilly
LLY
$1.02T
| $104M | 0.01% |
302,300
+245,000
| +428% | +$82.6M |
2016 Q3
26 quarters
|
|
780
EQT Corp
EQT
$31.4B
| $104M | 0.01% |
3,250,325
+35,733
| +1% | +$1.15M |
2013 Q2
39 quarters
|
|
781
Pool Corp
POOL
$5.87B
| $104M | 0.01% |
302,815
+187,447
| +162% | +$66.5M |
2013 Q2
39 quarters
|
|
782
PUT
ConocoPhillips
COP
$152B
| $104M | 0.01% |
1,044,500
+375,826
| +56% | +$41.1M |
2018 Q4
17 quarters
|
|
783
Brady Corp
BRC
$3.98B
| $103M | 0.01% |
1,915,665
-94,981
| -5% | -$4.97M |
2013 Q2
39 quarters
|
|
784
Sanofi
SNY
$95.7B
| $103M | 0.01% |
1,884,745
-1,591,811
| -46% | -$77.4M |
2013 Q2
39 quarters
|
|
785
Ambev
ABEV
$46.1B
| $102M | 0.01% |
36,312,283
+754,570
| +2% | +$1.97M |
2013 Q4
37 quarters
|
|
786
CALL
Madrigal Pharmaceuticals
MDGL
$11.5B
| $102M | 0.01% |
421,300
+411,300
| +4,113% | +$112M |
2022 Q4
1 quarter
|
|
787
AGCO
AGCO
$8.03B
| $102M | 0.01% |
754,588
+38,185
| +5% | +$5.16M |
2013 Q2
39 quarters
|
|
788
Plains All American Pipeline
PAA
$16.8B
| $102M | 0.01% |
8,147,138
+2,892,097
| +55% | +$36.1M |
2013 Q2
39 quarters
|
|
789
PUT
Bank of America
BAC
$376B
| $100M | 0.01% |
3,505,100
-747,900
| -18% | -$24.7M |
2013 Q2
39 quarters
|
|
790
iShares US Aerospace & Defense ETF
ITA
$12.2B
| $99.7M | 0.01% |
866,094
-165,584
| -16% | -$18.8M |
2013 Q3
38 quarters
|
|
|
ITCI
791
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $99.1M | 0.01% |
1,830,884
+332,970
| +22% | +$16.1M |
2017 Q3
22 quarters
|
|
|
EXE
792
Expand Energy Corp
EXE
$19.8B
| $98.9M | 0.01% |
1,300,566
+71,598
| +6% | +$5.89M |
2021 Q1
8 quarters
|
|
793
Carrier Global
CARR
$45.4B
| $98.4M | 0.01% |
2,151,210
-998,779
| -32% | -$44.7M |
2020 Q2
11 quarters
|
|
|
794
CALL
ConocoPhillips
COP
$152B
| $98.4M | 0.01% |
992,000
-220,400
| -18% | -$24.1M |
2018 Q2
19 quarters
|
|
|
HDV
795
iShares Core High Dividend ETF
HDV
$14.7B
| $98.3M | 0.01% |
4,836,970
+205,875
| +4% | +$4.23M |
2013 Q2
39 quarters
|
|
796
Corteva
CTVA
$7.95B
| $98.2M | 0.01% |
1,628,895
+197,226
| +14% | +$12M |
2019 Q2
15 quarters
|
|
|
EDR
797
DELISTED
Endeavor Group Holdings, Inc.
EDR
| $98.1M | 0.01% |
4,101,521
+527,916
| +15% | +$11.8M |
2021 Q2
7 quarters
|
|
798
American Water Works
AWK
$25.9B
| $97.9M | 0.01% |
668,426
+244,260
| +58% | +$36.2M |
2013 Q2
39 quarters
|
|
|
799
CALL
Alphabet (Google) Class A
GOOGL
$4.2T
| $97.7M | 0.01% |
941,900
+213,200
| +29% | +$20.5M |
2015 Q4
29 quarters
|
|
800
Shell
SHEL
$274B
| $96.9M | 0.01% |
1,684,473
-378,480
| -18% | -$22.3M |
2022 Q1
4 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.